Carolyn Barber, MD on Nostr: đź’Ş #Novavax submitted its application to the FDA today for its updated #COVID19 ...
đź’Ş #Novavax submitted its application to the FDA today for its updated #COVID19 #vaccine, which they report is active against current circulating variants, KP.2 and KP.3.
“Nonclinical data have demonstrated that Novavax's vax induces broad neutralization responses to JN.1 lineage viruses including those containing the F456L and R346T mutations, and to "FLiRT" & "FLuQE" variants.”👍
The co. intends to have doses in the U.S. for distribution by mid-July.Â
https://tinyurl.com/2we5mcdt
“Nonclinical data have demonstrated that Novavax's vax induces broad neutralization responses to JN.1 lineage viruses including those containing the F456L and R346T mutations, and to "FLiRT" & "FLuQE" variants.”👍
The co. intends to have doses in the U.S. for distribution by mid-July.Â
https://tinyurl.com/2we5mcdt